The PDA Technical Report No. 82 (TR 82) , published in March 2019, provides essential guidance on , a critical phenomenon in the pharmaceutical and biopharmaceutical industries . This report is a vital resource for ensuring patient safety by addressing the challenges of accurately detecting bacterial endotoxins in complex drug formulations. What is Low Endotoxin Recovery (LER)?
Published in , it provides a scientific framework for researchers and quality control professionals to address LER, which can lead to undetected endotoxins in sterile products. Guide to PDA Technical Report 82 1. Core Objectives pda technical report 82 pdf
If affiliated with a university, request the PDF via interlibrary loan. Some libraries have print copies that can be scanned for research purposes (fair use). The PDA Technical Report No
Container closure systems (glass vials, pre-filled syringes, stoppers) can adsorb endotoxins over time. The liquid phase tests negative, but the endotoxin is physically present on the container wall. What is Low Endotoxin Recovery (LER)
Biopharmaceutical products containing polysorbates and buffers (e.g., citrate or phosphate).